Dominantly inherited Alzheimer’s disease (DIAD) causes predictable biological changes
decades before the onset of clinical symptoms, enabling testing of interventions in the …

Background: This randomized, double-blind, placebo-controlled trial examined the efficacy
and safety of risperidone in the treatment of aggression, agitation, and psychosis in elderly …

Objective: To determine whether the prevalence of dementia, depression and/or disability in
older diabetic subjects warrants an active screening approach by diabetes health care …

Background The identification of people at risk of cognitive impairment is essential for improving
recruitment in secondary prevention trials of Alzheimer's disease. We aimed to test and …

Subjective memory complaint is common in later life. Its relationship to future risk of dementia
is unclear, although many reports have found a positive association. We designed the …

Eleven early-onset dementia families, all with affected individuals who have either presented
clinical symptoms of early onset familial Alzheimer's disease (EOFAD) or have been …

OBJECTIVE—The purpose of this study was to determine longitudinal predictors of cognitive
decline in older individuals with diabetes who did not have dementia. RESEARCH DESIGN …

We measured the concentration of apolipoprotein E (apoE) in plasma from 184 non-fasted
subjects in order to determine whether important variations might exist linking plasma apoE …

Objective: Although the APOE ϵ4 allele is associated with more rapid decline in memory in
healthy older adults, the significance of elevated cerebral β-amyloid (Aβ) load for longitudinal …

Introduction Quantitative in vivo measurement of brain amyloid burden is important for both
research and clinical purposes. However, the existence of multiple imaging tracers presents …